在Catalent,我们敏锐地意识到每一种生物药物都有不同的需求和挑战。这就是为什么我们为新的生物实体、细胞和基因疗法、生物仿制药、无菌注射剂和抗体药物结合物提供从开发和生物制造到填充/完成和包装的全面解决方案。
作为一家在欧洲和北美拥有最*进设施的全球生物制品领*者,我们拥有与全球跨国制药公司、小型虚拟公司等各种规模客户合作的经验。我们的先进技术,包括GPEx®、SMARTag®和腺相关病毒(AAV)载体,可以帮助您创建下一代疗法。我们的OneBio®集成产品利用Catalent的Follow the Molecular®开发和制造方法,为您提供从开发到供应的加速集成解决方案。
At Catalent, we are keenly aware that every biologic drug has different needs and challenges. That is why we provide comprehensive solutions from development and biomanufacturing to fill/finish and packaging for new biological entities, cell and gene therapies, biosimilars, sterile injectables and antibody-drug conjugates. As a global biologics leader with state-of-the-art facilities in Europe and North America, we have experience working with customers of all sizes from top global multinational pharma to small and virtual companies. Our advanced technologies including GPEx®, SMARTag®, and adeno-associated virus (AAV) vectors can help you create next generation therapies. Our OneBio® integrated offering leverages Catalent’s Follow the Molecule® development and manufacturing approach to provide you accelerated and integrated solutions from development to supply.